MX2018009088A - Composicion farmaceutica inyectable que incluye trabectedina para uso gastrointestinal externo y metodo para la fabricacion de la misma. - Google Patents

Composicion farmaceutica inyectable que incluye trabectedina para uso gastrointestinal externo y metodo para la fabricacion de la misma.

Info

Publication number
MX2018009088A
MX2018009088A MX2018009088A MX2018009088A MX2018009088A MX 2018009088 A MX2018009088 A MX 2018009088A MX 2018009088 A MX2018009088 A MX 2018009088A MX 2018009088 A MX2018009088 A MX 2018009088A MX 2018009088 A MX2018009088 A MX 2018009088A
Authority
MX
Mexico
Prior art keywords
trabectedin
inclusive
pharmaceutical composition
external use
injectable pharmaceutical
Prior art date
Application number
MX2018009088A
Other languages
English (en)
Inventor
Wang Likun
Xu Chen
Liu Kai
Sun Qiong
Yin Rong
Original Assignee
Jiangsu Hengrui Medicine Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hengrui Medicine Co filed Critical Jiangsu Hengrui Medicine Co
Publication of MX2018009088A publication Critical patent/MX2018009088A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica inyectable que incluye trabectedina para uso gastrointestinal externo y al método para la fabricación de la misma. Específicamente, la composición contiene trabectedina y un primer excipiente, el primer excipiente siendo seleccionado de entre uno, o más, de monosacáridos y polioles. La preparación en la presente invención tiene una calidad estable y puede ser aplicada a una producción en masa.
MX2018009088A 2016-02-04 2017-01-23 Composicion farmaceutica inyectable que incluye trabectedina para uso gastrointestinal externo y metodo para la fabricacion de la misma. MX2018009088A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610081052 2016-02-04
PCT/CN2017/072220 WO2017133544A1 (zh) 2016-02-04 2017-01-23 一种曲贝替定的可注射胃肠外用药物组合物及其制备方法

Publications (1)

Publication Number Publication Date
MX2018009088A true MX2018009088A (es) 2018-09-03

Family

ID=59499346

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018009088A MX2018009088A (es) 2016-02-04 2017-01-23 Composicion farmaceutica inyectable que incluye trabectedina para uso gastrointestinal externo y metodo para la fabricacion de la misma.

Country Status (14)

Country Link
US (1) US10610529B2 (es)
EP (1) EP3412293A4 (es)
JP (1) JP2019504061A (es)
KR (1) KR20180103965A (es)
CN (1) CN107427512B (es)
AU (1) AU2017215603A1 (es)
BR (1) BR112018015118A2 (es)
CA (1) CA3011527A1 (es)
HK (1) HK1244713A1 (es)
MX (1) MX2018009088A (es)
RU (1) RU2738741C2 (es)
TW (1) TWI720117B (es)
WO (1) WO2017133544A1 (es)
ZA (1) ZA201804964B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108276408B (zh) * 2018-04-19 2020-09-29 上海皓元医药股份有限公司 一种曲贝替定的中间体及其制备方法和用途
US20210169873A1 (en) * 2019-10-21 2021-06-10 RK Pharma Solutions LLC Storage-stable ready-to-use injectable formulations of Trabectedin
JP2023522890A (ja) 2020-04-15 2023-06-01 エバー バリンジェクト ゲーエムベーハー トラベクテジンおよびアミノ酸を含む組成物
US20230226051A1 (en) * 2022-01-20 2023-07-20 Extrovis Ag Trabectedin composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK285669B6 (sk) * 1998-04-06 2007-06-07 The Board Of Trustees Of The University Of Illinois Ekteinascidínová zlúčenina, farmaceutický prostriedok s jej obsahom a jej použitie
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
RS50510B (sr) * 2004-10-29 2010-03-02 Pharma Mar S.A., Sociedad Unipersonal Formulacije koje sadrže ekteinascidin i disaharid
GB201217439D0 (en) * 2012-09-28 2012-11-14 Topotarget As Combination therapy

Also Published As

Publication number Publication date
AU2017215603A1 (en) 2018-08-09
CN107427512B (zh) 2021-10-08
WO2017133544A1 (zh) 2017-08-10
RU2018128913A3 (es) 2020-06-23
RU2738741C2 (ru) 2020-12-16
JP2019504061A (ja) 2019-02-14
EP3412293A1 (en) 2018-12-12
CA3011527A1 (en) 2017-08-10
TWI720117B (zh) 2021-03-01
KR20180103965A (ko) 2018-09-19
US10610529B2 (en) 2020-04-07
EP3412293A4 (en) 2019-10-16
CN107427512A (zh) 2017-12-01
US20190030028A1 (en) 2019-01-31
ZA201804964B (en) 2019-12-18
RU2018128913A (ru) 2020-03-04
HK1244713A1 (zh) 2018-08-17
TW201728327A (zh) 2017-08-16
BR112018015118A2 (pt) 2018-12-18

Similar Documents

Publication Publication Date Title
MX2019011778A (es) Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma.
IL257956A (en) New carbohydrate antibodies, pharmaceutical preparations and their uses
MX2018009088A (es) Composicion farmaceutica inyectable que incluye trabectedina para uso gastrointestinal externo y metodo para la fabricacion de la misma.
MX2019001352A (es) Hidroxiapatita permanentemente polarizada, proceso para su fabricación y sus usos.
HRP20181333T1 (hr) Novi derivati indola i pirola, metoda za njihovu proizvodnju i farmaceutski pripravci koji ih sadržavaju
EP3351589A4 (en) COMPOSITION, MICROFIBROUS CELLULOSE MATERIAL AND METHOD FOR PRODUCING A MATERIAL OF MICROFIBRE CELLULOSE
MX2016008369A (es) Composicion farmaceutica que incluye palonosetron.
MX2019011758A (es) Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma.
MX2017001487A (es) Sofosbuvir en forma cristalina y proceso para su preparacion.
WO2016033437A3 (en) Polyethers, polyamines, polythioethers, and methods for making same
MX2017015137A (es) Composicion farmaceutica oral de dosis diaria de isotretinoin.
HK1245794A1 (zh) 咪唑並噁嗪晶體、含有所述晶體的藥物組合物和製備所述晶體的方法
HRP20200104T8 (hr) Novi heterociklični spoj, metoda za pripremu istog, i farmaceutska kompozicija koja sadrži isto
BR112017011275A2 (pt) composição, e, processo para a produção de xarope de glicose.
GB201515411D0 (en) Substituted materials, process for the production and uses thereof
EP3442658C0 (en) DERMOCOSMETIC COMPOSITION, METHOD FOR PRODUCING THE TOPICAL COMPOSITION, METHOD FOR STRENGTHENING FRAGILE NAILS AND USE OF THE COMPOSITION
MX2017015322A (es) Composicion farmaceutica oral de isotretinoin.
WO2015095659A3 (en) Indirubin solid dispersion composition
EP3261138A4 (en) Piezoelectric ptzt film, and process for producing liquid composition for forming said piezoelectric film
MX2016015846A (es) Composicion en polvo de sorbitol y goma de mascar que comprende esta composicion.
PH12019500992A1 (en) Directly tablettable matrix for producing tablets with extended active substance delivery
WO2016142409A3 (en) Binder composition and its use in processes for the production of wood fibre boards
MX2017015505A (es) Composicion de preparacion solida que contiene pranlukast con biodisponibilidad mejorada y metodo para preparar la misma.
MX2018014260A (es) Una composicion farmaceutica que comprende racecadotrilo y procedimiento para preparar la misma.
PH12019501689A1 (en) Composition comprising immediate release and extended release capecitabine